ELI LILLY & Co (LLY) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, ELI LILLY reported revenue of $65.18B, up 44.7% from $45.04B the year before. Net income was $20.64B (a 31.7% net margin), or $22.95 per diluted share. Gross margin was 83.0% and operating margin was 66.0%. Operating activities generated $16.81B of cash. At fiscal year end, ELI LILLY held $112.48B in total assets against $85.94B in total liabilities, including $7.27B of cash and equivalents.
Open the full interactive ELI LILLY financials → Quarterly statements, key ratios, valuation history and price charts.
ELI LILLY Key Stats
| Share Price | $1,166.51 |
|---|---|
| Market Cap | $1.04T |
| P/E Ratio | 50.8 |
| Dividend Yield | 0.55% |
| Revenue YoY Growth | +44.7% |
| 52-Week Range | $794.56 – $1,280.34 |
| Shares Outstanding | 892.4 million (basic, 2026 Q2) |
ELI LILLY Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $24.54B | $28.32B | $28.54B | $34.12B | $45.04B | $65.18B |
| Cost of Goods Sold | $5.48B | $7.31B | $6.63B | $7.08B | $8.42B | $11.05B |
| Gross Profit | $19.06B | $21.01B | $21.91B | $27.04B | $36.62B | $54.13B |
| Operating Income | $6.85B | $7.55B | $8.28B | $19.64B | $28.03B | $43.03B |
| Pre-Tax Income | $7.23B | $6.16B | $6.81B | $6.55B | $12.68B | $25.73B |
| Income Tax | $1.04B | $573.8M | $561.6M | $1.31B | $2.09B | $5.09B |
| Net Income | $6.19B | $5.58B | $6.24B | $5.24B | $10.59B | $20.64B |
| Diluted EPS | $6.79 | $6.12 | $6.90 | $5.80 | $11.71 | $22.95 |
ELI LILLY Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $17.60B | $19.29B | $19.80B | $22.97B |
| Net Income | $5.58B | $6.64B | $7.40B | $7.09B |
| Diluted EPS | $6.21 | $7.38 | $8.26 | $7.94 |
ELI LILLY Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $3.66B | $3.82B | $2.07B | $2.82B | $3.27B | $7.27B |
| Current Assets | $17.46B | $18.45B | $18.03B | $25.73B | $32.74B | $55.63B |
| Total Assets | $46.63B | $48.81B | $49.49B | $64.01B | $78.71B | $112.48B |
| Current Liabilities | $12.48B | $15.05B | $17.14B | $27.29B | $28.38B | $35.23B |
| Total Long-Term Debt | $16.59B | $16.74B | $14.82B | $19.10B | $29.47B | $40.87B |
| Total Liabilities | $40.99B | $39.83B | $38.84B | $53.23B | $64.52B | $85.94B |
| Shareholders' Equity | $5.64B | $8.98B | $10.65B | $10.77B | $14.19B | $26.54B |
ELI LILLY Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $6.50B | $7.26B | $7.08B | $4.24B | $8.82B | $16.81B |
| Cash From Investing | -$2.26B | -$2.76B | -$3.26B | -$7.15B | -$9.30B | -$10.97B |
| Cash From Financing | -$3.14B | -$4.13B | -$5.41B | $3.50B | $1.23B | -$2.21B |
| Dividends Paid | $2.69B | $3.09B | $3.54B | $4.07B | $4.68B | $5.38B |
Figures from ELI LILLY's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full ELI LILLY financials page for every line item.
ELI LILLY Company Profile
| Ticker | LLY |
|---|---|
| Exchange | NYSE |
| Industry | Pharmaceutical Preparations |
| Headquarters | Indianapolis, Indiana |
| Incorporated in | Indiana |
| Fiscal Year End | December 31 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0000059478 |
Frequently Asked Questions
What was ELI LILLY's revenue in fiscal 2025?
ELI LILLY (LLY) reported revenue of $65.18B for fiscal 2025.
What is ELI LILLY's annual revenue history?
ELI LILLY's annual revenue by fiscal year: 2020: $24.54B; 2021: $28.32B; 2022: $28.54B; 2023: $34.12B; 2024: $45.04B; 2025: $65.18B.
What was ELI LILLY's net income in fiscal 2025?
ELI LILLY reported net income of $20.64B for fiscal 2025.
What was ELI LILLY's earnings per share (EPS) in fiscal 2025?
ELI LILLY's diluted EPS was $22.95 for fiscal 2025 (adjusted for any later stock splits).
What was ELI LILLY's revenue last quarter?
In its most recent reported quarter (2026 Q2), ELI LILLY reported revenue of $22.97B.
How much debt does ELI LILLY have?
ELI LILLY reported $40.87B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of ELI LILLY are outstanding?
ELI LILLY reported a weighted average of 892.4 million basic shares outstanding in 2026 Q2.
What is ELI LILLY's market cap?
Based on its latest closing price, ELI LILLY (LLY) has a market capitalization of about $1.04T.
When does ELI LILLY's fiscal year end?
ELI LILLY's fiscal year end, as registered with the SEC, is December 31.
Where is ELI LILLY headquartered?
ELI LILLY lists its business address in Indianapolis, Indiana in its SEC filings.